(R)-Apremilast

CAS No. 608141-44-2

(R)-Apremilast( (R)-CC-10004 )

Catalog No. M26405 CAS No. 608141-44-2

(R)-Apremilast is the enantiomer of Apremilast and one of the isoindoline derivatives.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 78 In Stock
5MG 77 In Stock
10MG 117 In Stock
25MG 235 In Stock
50MG 346 In Stock
100MG 519 In Stock
200MG 728 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (R)-Apremilast
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-Apremilast is the enantiomer of Apremilast and one of the isoindoline derivatives.
  • Description
    (R)-Apremilast is the enantiomer of Apremilast and one of the isoindoline derivatives.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (R)-CC-10004
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    608141-44-2
  • Formula Weight
    460.5
  • Molecular Formula
    C22H24N2O7S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (217.16 mM)
  • SMILES
    CCOc1cc(ccc1OC)[C@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Baughman RG, Martin KL, Singh RK, Stoffer JO. 2,4-Dinitrophenylhydrazones of 2,4-dihydroxybenzaldehyde, 2,4-dihydroxyacetophenone and 2,4-dihydroxybenzophenone. Acta Crystallogr C. 2004 Feb;60(Pt 2):o103-6.
molnova catalog
related products
  • MC-Val-Cit-PAB

    MC-Val-Cit-PAB is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate. FDA approved drugs such as brentuximab vedotin use this linker.

  • Fibrinopeptide A, hu...

    Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which binds to the central region of fibrinogen and catalyzes cleavage of the 2 short peptides, the 16-residue fibrinopeptide A (FpA) and the 14-residue fibrinopeptide B (FpB), located at the NH2-termini of the Aα and Bβ chains, respectively.

  • RIG012

    RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM (measured by NADH-coupled ATPase), and it inhibits the expression of IFN-β and ISG hRsad2.